5457 |
Left Main Revascularization: Data Supports PCI in Most Cases |
Gregg W. Stone |
Apr. 08. 22 |
5456 |
Most Updated IPD Meta-Analysis for LM Revascularization |
Brian Bergmark |
Apr. 08. 22 |
5455 |
Coronary Physiology in Severe AS: Decision-Making in TAVR Patients |
Nils Johnson |
Apr. 08. 22 |
5454 |
Vascular Inflammation in Plaque Rupture VS. Plaque Erosion: PCAT Attenuation |
Ik-Kyung Jang |
Apr. 08. 22 |
5453 |
Case #2: PCI with Cre8¢â EVO in DM Patient |
Salvatore Colangelo |
Apr. 08. 22 |
5452 |
Case #1: PCI with Cre8¢â EVO in DM Patient |
Daniel Aradi |
Apr. 08. 22 |
5451 |
Latest Updates on AES Clinical Studies |
Rafael Romaguera |
Apr. 08. 22 |
5450 |
Cre8¢â EVO: Paving the Way for DES Efficacy in Diabetics |
Gennaro Sardella |
Apr. 08. 22 |
5449 |
Lifelong Antiplatelet Therapy After PCI for Prevention of Ischemic Events |
Yongwhi Park |
Apr. 08. 22 |
5448 |
Updated Antiplatelet Approaches for ACS Patients; Tailored DAPT Strategy in De-escalation Era |
So-Yeon Choi |
Apr. 08. 22 |